Valuation: Tempus AI, Inc.

Capitalization 10.01B 8.48B 7.8B 7.39B 13.69B 927B 13.93B 91.4B 35.84B 449B 37.56B 36.78B 1,583B P/E ratio 2026 *
-33.6x
P/E ratio 2027 * -52.4x
Enterprise value 10.64B 9.01B 8.29B 7.85B 14.54B 984B 14.8B 97.09B 38.07B 477B 39.9B 39.07B 1,681B EV / Sales 2026 *
6.68x
EV / Sales 2027 * 5.43x
Free-Float
39.62%
Yield 2026 *
-
Yield 2027 * -
1 day+2.66%
1 week+30.11%
Current month+23.55%
1 month+14.75%
3 months-20.56%
6 months-36.35%
Current year-5.39%
1 week 42.54
Extreme 42.54
58.04
1 month 41.73
Extreme 41.73
58.04
Current year 41.73
Extreme 41.73
76.33
1 year 39.01
Extreme 39.01
104.32
3 years 22.89
Extreme 22.89
104.32
5 years 22.89
Extreme 22.89
104.32
10 years 22.89
Extreme 22.89
104.32
Manager TitleAgeSince
Chief Executive Officer 56 31/07/2015
Director of Finance/CFO 40 31/07/2017
Chief Tech/Sci/R&D Officer 49 24/10/2022
Director TitleAgeSince
Chairman 56 31/07/2015
Director/Board Member 54 28/10/2019
Director/Board Member 74 31/08/2017
Change 5d. change 1-year change 3-years change Capi.($)
+2.66%+30.11%+38.12% - 10.01B
+2.22%+5.51%+0.78%-7.33% 48.69B
+0.99%+4.59%+40.22%+21.40% 35.92B
-0.43%+54.13%+304.33%+512.40% 31.26B
-0.72%+3.91%+37.10%+32.51% 29.77B
+2.62%+5.45%+22.62%-12.96% 29.62B
+0.63%+2.17%+48.12%+200.79% 15.1B
+0.96%+5.48%+75.71%+171.60% 14.87B
+0.87%+8.85%+40.89%+13.75% 14.5B
-6.22%-0.52%+3,641.35%+3,861.59% 14.18B
Average +0.36%+11.84%+424.92%+532.64% 24.39B
Weighted average by Cap. +0.66%+11.90%+275.58%+331.50%

Financials

2026 *2027 *
Net sales 1.59B 1.35B 1.24B 1.17B 2.18B 147B 2.21B 14.53B 5.7B 71.41B 5.97B 5.85B 252B 1.94B 1.65B 1.51B 1.43B 2.66B 180B 2.7B 17.74B 6.96B 87.18B 7.29B 7.14B 307B
Net income -293M -248M -229M -216M -401M -27.13B -408M -2.68B -1.05B -13.15B -1.1B -1.08B -46.35B -188M -159M -146M -138M -257M -17.37B -261M -1.71B -672M -8.42B -704M -690M -29.68B
Net Debt 623M 528M 486M 460M 852M 57.65B 867M 5.69B 2.23B 27.95B 2.34B 2.29B 98.5B 534M 452M 416M 394M 730M 49.4B 743M 4.87B 1.91B 23.95B 2B 1.96B 84.4B
Logo Tempus AI, Inc.
Tempus AI, Inc. is a technology company. The Company provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The Company's AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.
Employees
3,800
Date Price Change Volume
17/04/26 55.87 $ +2.66% 6,580,425
16/04/26 54.42 $ -3.53% 8,756,645
15/04/26 56.41 $ +13.89% 12,363,260
14/04/26 49.53 $ +7.72% 6,546,697
13/04/26 45.98 $ +7.08% 5,797,806
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
55.87USD
Average target price
72.40USD
Spread / Average Target
+29.59%

Quarterly revenue - Rate of surprise